Oncology Xagena
A meta-analysis did not find strong evidence of a marked increase in the risk of cancer among personal hair dye users. There is growing concern about a possible increase in the risk of cancer amon ...
Bladder cancer occurs about three times more often in men than women. Its also more likely to strike older adults. Environmental factors such as tobacco and industrial chemicals can increase the ri ...
Researchers have isolated compounds from the vegetable broccoli that they believe may help prevent or slow the progress of bladder cancer. The current work builds on a major study conducted six yea ...
Debate exists on how many cancer deaths are preventable in principle - estimates range from 50 percent to 80 percent - but most researchers agree that tobacco use ( mostly smoking ) accounts for the m ...
Axel Ullrich, at the Max Planck Institute of Biochemistry in Martinsried, Germany, already showed at the beginning of the 1990s that blocking blood vessel development in a tumour slows down its growth ...
Final results of a Phase II clinical trial of MAGE-A3 Antigen-Specific Cancer Immunotherapeutic ( ASCI ) in MAGE-A3 positive patients with stage IB or II non-small cell lung cancer ( NSCLC ), have sho ...
A family history of cancer increases the risk of other members of the family developing not only the same cancer ( known as a concordant cancer ) but also a different ( discordant ) cancer, according ...
Data on the investigational use of Pembrolizumab ( Keytruda ), an anti-PD-1 agent, in PD-L1 positive, advanced urothelial cancer ( also known as bladder cancer ) presented at ESMO ( European Society f ...
Early results from a pivotal phase II study, IMvigor 210, of the investigational cancer immunotherapy Atezolizumab ( anti-PDL1; MPDL3280A ) in people with locally advanced or metastatic urothelial car ...
New data from KEYNOTE-001, a phase 1b study evaluating Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, in naïve and previously-treated patients with advanced non-small cell lung cancer ( NSCLC ) wer ...
The International Agency for Research on Cancer ( IARC ) has classified outdoor air pollution as a cancer-causing agent ( carcinogen ). The IARC is part of the World Health Organization, and is one of ...
Updated results from the pivotal phase II study, IMvigor 210, of the investigational cancer immunotherapy Atezolizumab ( MPDL3280A ) in people with locally advanced or metastatic urothelial carcinoma ...
The results for Nivolumab ( Opdivo ) in the cohort of patients with metastatic urothelial cancer ( n=78 ), the most common type of bladder cancer, after Platinum-based therapy from CheckMate -032, a p ...
A treatment harnesses the immune system to shrink tumors in bladder cancer patients that cannot take the most effective chemotherapy. These are the findings of a clinical trial led by researchers at ...
With few treatment options available to patients with advanced bladder cancer, investigators are looking for novel molecular targets. In a study published in The American Journal of Pathology, resea ...
